Premium
A rationale for the use of non‐steroidal anti‐androgens in the management of prostate cancer
Author(s) -
Benson Ralph C.
Publication year - 1992
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.2990210513
Subject(s) - flutamide , prostate cancer , medicine , prostate , antiandrogen , agonist , androgen , management of prostate cancer , hormonal therapy , cancer , urology , hormone , oncology , endocrinology , androgen receptor , receptor
Flutamide is a non‐steroidal anti‐androgen which has been used to treat prostate cancer. Results to date indicate that flutamide is as effective as other conventional therapy. It has only moderate activity in patients in whom conventional hormonal therapy has previously failed, but appears to be beneficial when combined with an LHRH agonist.